Design (QbD) and Risk Assessment Approach for Formulation and Evaluation of Clobetasol Proionate Nanoemulgel for Anti Psoriatic Activity
Sábháilte in:
| Príomhchruthaitheoir: | |
|---|---|
| Formáid: | Tráchtas LEABHAR |
| Teanga: | Béarla |
| Ábhair: | |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
MARC
| LEADER | 00000nam a22000007a 4500 | ||
|---|---|---|---|
| 008 | 230508b |||||||| |||| 00| 0 eng d | ||
| 100 | |a Devadiga Shanaika |9 580 | ||
| 245 | |a Design (QbD) and Risk Assessment Approach for Formulation and Evaluation of Clobetasol Proionate Nanoemulgel for Anti Psoriatic Activity | ||
| 502 | |a M.Pharm. + MBA | ||
| 518 | |a 2023 | ||
| 650 | |a Quality Assurance |9 536 | ||
| 720 | |a Dr. Sanjay Sharma | ||
| 999 | |c 8697 |d 8697 | ||